Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p19ARF targets certain E2F species for degradation.

F Martelli1, T Hamilton, D P Silver

  • 1Department of Cancer Biology and Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 29, 2001
PubMed
Summary

The tumor suppressor p19ARF reduces levels of E2F1, E2F2, and E2F3 transcription factors, inhibiting the growth of p53-deficient cells. This suggests p19ARF has a broader tumor-suppressive role beyond the p53 pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Insecticide Resistance Alters Oviposition Preference in <i>Drosophila melanogaster</i>.

Ecology and evolution·2026
Same author

Mechanisms of clinical resistance to selective FGFR2 inhibition by lirafugratinib.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

miR-210 overexpression increases pressure overload-induced cardiac fibrosis.

Non-coding RNA research·2025
Same author

Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer.

Cell cycle (Georgetown, Tex.)·2023

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • p19ARF is a known tumor suppressor that inhibits cell growth in p53-deficient cells via an unclear mechanism.
  • The p53 pathway is a critical regulator of cell cycle arrest and apoptosis in response to cellular stress.

Purpose of the Study:

  • To elucidate the mechanism by which p19ARF suppresses the growth of p53-deficient cells.
  • To investigate the interaction between p19ARF and transcription factors involved in cell proliferation.

Main Methods:

  • Co-immunoprecipitation assays to detect protein complexes.
  • Western blotting to assess protein levels and turnover.
  • Quantitative real-time PCR to measure mRNA expression.
  • Flow cytometry and cell proliferation assays.

Related Experiment Videos

Main Results:

  • p19ARF forms complexes with transcription factors E2F1, E2F2, and E2F3.
  • p19ARF expression leads to decreased levels of E2F1, E2F2, and E2F3 through enhanced protein degradation.
  • p19ARF-induced degradation of E2F1 requires a functional proteasome and results in E2F1 relocalization to nucleoli.
  • Suppression of proliferation in p53-deficient cells by p19ARF is partially rescued by ectopic E2F1 expression.

Conclusions:

  • p19ARF functions as a tumor suppressor by targeting specific E2F transcription factors for degradation.
  • This targeting of E2F proteins represents a novel mechanism contributing to p19ARF's anti-proliferative effects.
  • p19ARF's tumor-suppressive activity may involve both p53-dependent and p53-independent pathways, with E2F modulation playing a key role.